Please do not adjust margins
Green Chemistry
Page 6 of 7
DOI: 10.1039/C5GC01028D
ARTICLE
Journal Name
Mekelleche and D. Villemin, J. Theor. Comput. Chem., 2010,
, 1021.
a) T. L. P. Galvão, I. M. Rocha, M. D. M. C. Ribeiro da Silva
and M. A. V. Ribeiro da Silva, J. Phys. Chem. A, 2013, 117
12668; b) L.-h. Gan, Q. Chang and J. Zhou, Chin. J. Chem.
Phys., 2013, 26, 54; c) J. P. Cerón-Carrasco and D. Jacquemin,
Chemphyschem 2011, 12, 2615; d) R. M. Balabin, J Chem
Phys. 2009, 131, 154307; e) R. Sanchez, B. M. Giuliano, S.
Melandri and W. Caminati, Chem. Phy. Lett., 2006, 425, 6; f)
E. Constantino, X. Solans-Monfort, M. Sodupe and J. Bertran,
Chemical Physics, 2003, 295, 151.
R. K. Henderson, C. Jim´enez-Gonz´ alez, D. J. C. Constable, S.
R. Alston, G. G. A. Inglis, G. Fisher, J. Sherwood, S. P. Binksa
and A. D. Curzon, Green Chem., 2011, 13, 854.
a) P. T. Anastas and John C. Warner, Green Chemistry:
Theory and Practice Oxford University Press (May 25, 2000);
b) B. M. Trost, Acc. Chem. Res., 2002, 35, 695.
Notes and references
9
General procedure for the cinnamylaion of tautomerizable
heteroarenes: In a glove box, to an oven dried 4 mL glass vial
equipped with a stirring bar, 4-hydroxy quinazoline 1a (0.731 g,
0.5 mmol), cinnamyl alcohol 2da (0.067 g, 0.5 mmol, 1 equiv), Pd
(PPh3)4 (0.029 g, 0.025 mmol, 5 mol%) followed by DMC (1 mL)
were added and the reaction mixture was stirred at 100 °C. After
stipulated time period, the reaction mixture was cooled to rt,
diluted with MeOH (2 x 10 mL) and passed through bed of celite
to remove catalyst. The organic layer was dried over anhydrous
Na2SO4 and concentrated under reduced pressure. The crude
products were adsorbed on to silica gel and passed through the
column (eluent: Hexane/EtOAc) to get analytically pure product
6
,
7
8
9
3b as white solid (0.118 g, 90%); 1H NMR (400 MHz, CDCl3):
δ
8.36 (d, J = 7.9 Hz, 1H), 8.12 (s, 1H), 7.73-7.79 (m, 2H), 7.51-7.55
(m, 2H), 7.26-7.39 (m, 5H), 6.68 (d, J = 15.8 Hz, 1H), 6.32-6.39
(m, 1H), 4.81 (d, J = 2.4 Hz, 2H); 13C NMR (100 MHz, CDCl3):
δ
a) H. P. Kokatla and M. K. Lakshman, Org. Lett., 2010, 12
,
160.9, 148.2, 146.1, 135.8, 134.5, 134.3, 128.6, 128.3, 127.5,
127.3, 126.8, 126.6, 122.8, 122.2, 48.2; HRMS (ESI-TOF) m/z: [M
+ H]+ Calcd for C17H15N2O 263.1184, Found 263.1178.
4478; b) F.-A. Kang, Z. Sui and W. V. Murray, J. Am. Chem.
Soc., 2008, 130, 11300.
10 a) D. Ranganathan, R. Rathi, K. Keshavan and W. P. Singh,
Tetrahedron, 1986, 42, 4873; b) H. F Stewart and R. P.
Seibert, J. Org. Chem., 1968, 33, 4560.
11 a) A. C. S. Reddy, B. Narsaiah and R. V. Venkataratnam,
Tetrahedron Lett., 1996, 37, 2829; b) T. Ikariya, Y. Ishikawa,
K. Hirai and S. Yoshikawa, Chem. Lett., 1982, 1815; c) T. G.
Schenck and B. Bosnich, J. Am. Chem. Soc. 1985, 107, 2058.
12 For tautomerizable heteroarenes, the lactam (oxo) form is
generally more favored over lactim (hydroxy) form in both
solid and solution phase. High temperature, bases and other
additives can accelerate the tautomerization from the
former to the later. The formation of N-allylated product in
different tautomerizable heteroarenes in high yields
1
2
S. D. Roughley and A. M. Jordan, J. Med. Chem., 2011, 54,
3451.
Review articles: a) B. M. Trost and D. L. Van Vranken, Chem.
Rev., 1996, 96, 395; b) B. M. Trost and M. L. Crawley, Chem.
Rev., 2003, 103, 2921; c) B. M. Trost, M. R. Machacek and A.
Aponick, Acc. Chem. Res., 2006, 39
publications: d) T. Maji and J. A. Tunge, Org. Lett., 2014, 16
,
747. Recent
,
5072; e) K. Aoyagi, H. Nakamura, Y. Yamamoto, M.
Billamboz, F. Mangin, N. Drillaud, C. Chevrin-Villette, E.
Banaszak-Léonard and C. Len, J. Org. Chem., 2014, 79, 493; f)
J. Liu, X, Huo, T. Li, Z. Yang, P. Xi, Z. Wang and B. Wang,
Chem. Eur. J. 2014, 20, 11549; g) S.-C. Sha , J. Zhang, P. J.
Carroll and P. J. Walsh, J. Am. Chem. Soc., 2013, 135, 17602;
h) M. Patil and W. Thiel, Chem. Eur. J., 2012, 18, 10408; i) Y.
[especially in case of 2-hydroxypyridine 1p
,
4-
hydroxypyrimidine 1q (nonbenzo-annelated analogue of 1a),
and 2-hydroxypyrazine 1r where the oxo-hydroxy
equilibrium is more labile] suggests the existence of more
than one pathway for the chemoselective N-allylation.
13 Possible facilitation in the formation of the allylpalladium
complexes via in-situ formation of mixed carbonates was
ruled out by performing a blank reaction in the absence of 1a
under optimized condition. No formation of mixed carbonate
was observed See: S. B. Lang, T. M. Locascio and J. A. Tunge,
Org. Lett., 2014, 16, 4308.
Feng-Quan, F.-Y. Suna and F.-S. Hana, Tetrahedron, 2012, 68
,
6837; j) J. Zhang, C. Stanciu, B. Wang, M. M. Hussain, C.-S.
Da, P. J. Carroll, S. D. Dreher and P. J. Walsh, J. Am. Chem.
Soc., 2011, 133, 20552.
3
4
R. A. Shenvi, D. P. O’Malley and P. S. Baran, Acc. Chem. Res.,
2009, 42, 530.
a) Antitumor: D.-J. Baek, Y.-K. Park, H.Il Heo, M. Lee, Z. Yang
and M. Choi, Bioorg. Med. Chem. Lett., 1998, 8, 3287; b)
Antibacterial: R. Bouley, M. Kumarasiri, Z. Peng, L. H. Otero,
W. Song, M. A. Suckow, V. A. Schroeder, W. R. Wolter, E.
Lastochkin, N. T. Antunes, H. Pi, S. Vakulenko, J. A. Hermoso,
14 a) F. Ozawa, H. Okamoto, S. Kawagishi, S. Yamamoto, T.
Minami and M. Yoshifuji, J. Am. Chem. Soc., 2002, 124,
10968; b) I. Usui, S. Schmidt, M. Keller and B. Breit, Org.
Lett., 2008, 10, 1207; c) H. Kinoshita, H. Shinokubo and K.
M. Chang and S. Mobashery, J. Am. Chem. Soc., 2014, 137
,
1738; c) Antimalarial: Y. Takaya, H. Tasaka, T. Chiba, K. Uwai,
M.-a. Tanitsu, H.-S. Kim,Y. Wataya, M. Miura, M. Takeshita
and Y. Oshima, J. Med. Chem., 1999, 42, 3163; d) Anti-
diabetic: M. S. Malamas and J. Millen, J. Med. Chem., 1991,
34, 1492; e) Anti-allergic: N. P. Peet, L. E. Baugh, S. Sunder, J.
E. Lewis, E. H. Matthews, E. L. Olberding and D. N. Shah, J.
Med. Chem., 1986, 29, 2403; f) Non-nucleoside reverse
transcriptase inhibitor: J. W. Corbett, S. S. Ko, J. D. Rodgers,
L.A. Gearhart, N. A. Magnus, L.T. Bacheler, S. Diamond, S.
Jeffrey, R. M. Klabe, B. C. Cordova, S. Garber, K. Logue, G. L.
Trainor, P. S. Anderson and S. K. Erickson-Viitanen, J. Med.
Chem., 2000, 43, 2019; g) CNS depressants: J. F. Wolfe, T. L.
Rathman, M. C. Sleevi, J. A. Campbell and T. D. Greenwood,
J. Med.Chem., 1990, 33, 161.
Oshima, Org. Lett., 2004,
Miyamoto, J. Ipposhi, T. Ohshima and K. Mashima, Org. Lett.,
2007, , 3371; e) I. Usui, S. Schmidt and B. Breit, Org. Lett.,
2009, 11, 1453; f) R. Takeuchi and M. Kashio, J. Am. Chem.
Soc., 1998, 120, 8647; g) M. Kimura, M. Futamata, R. Mukai
and Y. Tamaru, J. Am. Chem. Soc., 2005, 127, 4592; h) K.
6, 4085; d) M. Utsunomiya, Y.
9
Manabe and S. Kobayashi, Org. Lett., 2003, 5, 3241; i) P.
Mukherjee and R. A. Widenhoefer, Org. Lett., 2010, 12,
1184; j) S. Chandrasekhar, V. Jagadeshwar, B. Saritha and C.
Narsihmulu, J. Org. Chem., 2005, 70, 6506; k) D. Banerjee, R.
V. Jagadeesh, K. Junge, H. Junge and M. Beller,
ChemSusChem, 2012,
5, 2039; l) D. Banerjee, R. V.
Jagadeesh, K. Junge, H. Junge and M. Beller, Angew. Chem.,
2012, 124, 11724; m) T. Ohshima, Y. Miyamoto, J. Ipposhi, Y.
Nakahara, M. Utsunomiya and K. Mashima, J. Am. Chem.
Soc., 2009, 131, 14317; n) Z.-L. Tao, W.-Q. Zhang, D.-F. Chen,
A. Adele and L.-Z. Gong, J. Am. Chem. Soc., 2013, 135, 9255.
5
a) J. Powling and H. J. Bernstein, J. Am. Chem. Soc., 1951, 73,
4353; b) M. W. Wong, K. B. Wiberg and M. J. Frisch, J. Am.
Chem. Soc., 1992, 114, 1645; c) J. N. Spencer, Eric S.
Holmboe, Mindy R. Kirshenbaum, Daniel W. Firth and P. B.
Pinto, Canadian J. Chem., 1982, 60, 1178; d) I. E. Charif, S. M.
6 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins